Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year

SIMPLE SUMMARY: Measurable residual disease monitoring is an important prognostic tool in haematological malignancies commonly performed by two modalities: flow cytometry and molecular methods. In this paper, we studied consecutive adult participants requiring flow cytometric measurable residual dis...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Linde, Riana, Gatt, Prudence N., Smith, Sandy, Fernandez, Marian A., Vaughan, Lachlin, Blyth, Emily, Curnow, Jennifer, Brown, David A., Tegg, Elizabeth, Sasson, Sarah C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605425/
https://www.ncbi.nlm.nih.gov/pubmed/37894431
http://dx.doi.org/10.3390/cancers15205064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605425/
https://www.ncbi.nlm.nih.gov/pubmed/37894431
http://dx.doi.org/10.3390/cancers15205064

Ejemplares similares